ENSC Stock Summary and Trading Ideas (Ensysce Biosciences | NASDAQ:ENSC)

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Ensysce Biosciences trades on the NASDAQ stock market under the symbol ENSC.

As of June 25, 2026, ENSC stock price was flat at $0.28 with 551,022 million shares trading.

ENSC has a beta of 2.16, meaning it tends to be more sensitive to market movements. ENSC has a correlation of 0.06 to the broad based SPY ETF.

ENSC has a market cap of $4.35 million. This is considered a Sub-Micro Cap stock.

Last quarter Ensysce Biosciences reported $960,999 in Revenue and -$.52 earnings per share. This fell short of revenue expectation by $-939,001 and exceeded earnings estimates by $.21.

In the last 3 years, ENSC traded as high as $39.60 and as low as $.23.

The top ETF exchange traded funds that ENSC belongs to (by Net Assets): VXF.

ENSC has underperformed the market in the last year with a return of -87.1%, while the SPY ETF gained +22.3%. In the last 3 month period, ENSC fell short of the market, returning -48.7%, while SPY returned +12.7%. However, in the most recent 2 weeks ENSC has outperformed the stock market by returning +11.4%, while SPY returned +1.5%.

ENSC support price is $.26 and resistance is $.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ENSC shares will trade within this expected range on the day.